Qiren Huang

12PUBLICATIONS
13CO-AUTHORS
Epidemiological modellingPharmacogenomicsPredictive and prognostic markersMedical biochemistry - lipidsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 27, 2025
Asprosin Aggravates Tubular Epithelial Cell Injury and Phenotypic Transformation via Mitochondrial Dynamics Disorder Mediated by Excessive Drp1 SUMOylation in Diabetic Nephropathy Mice.

Qianqian Huang, Xiaowei Xiong, Sheng Chen

|Jun 25, 2025
Asprosin attenuates diabetic cardiomyopathy through inhibiting autophagy mediated by AMPK/mTOR/ULK1 pathway.

Yuan Wang, Wentao Liu, Chen Liu

|May 07, 2025
Pro-Atherosclerotic Effects of Osteopontin Is Contributed to Promoting Foam Cell Formation Derived From VSMCs by Inhibiting Cholesterol Efflux.

Wentao Liu, Yuan Wang, Chen Liu

|Mar 27, 2025
Correction: Yin et al. Angiogenesis-Browning Interplay Mediated by Asprosin-Deficiency Contributes to Weight Loss in Mice with Obesity. Int. J. Mol. Sci. 2022, 23, 16166.

Tingting Yin, Sheng Chen, Guohua Zeng

|Feb 19, 2024
Asprosin contributes to pathogenesis of obesity by adipocyte mitophagy induction to inhibit white adipose browning in mice.

Sheng Chen, Wanwan Yuan, Qianqian Huang

|Dec 16, 2023
SUMOylation and coupling of eNOS mediated by PIAS1 contribute to maintenance of vascular homeostasis.

Li Wang, Wenjing Zeng, Chaowen Wang

Pageof 2

Frequent Collaborators

2 joint publications

Li Wang

2 joint publications

Chaowen Wang

2 joint publications

Sheng Chen

2 joint publications

Xiaowei Xiong